EP2863890A4 - Fenofibrate formulation - Google Patents

Fenofibrate formulation

Info

Publication number
EP2863890A4
EP2863890A4 EP12880074.5A EP12880074A EP2863890A4 EP 2863890 A4 EP2863890 A4 EP 2863890A4 EP 12880074 A EP12880074 A EP 12880074A EP 2863890 A4 EP2863890 A4 EP 2863890A4
Authority
EP
European Patent Office
Prior art keywords
fenofibrate formulation
fenofibrate
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP12880074.5A
Other languages
German (de)
French (fr)
Other versions
EP2863890A1 (en
Inventor
Sarat C Chattaraj
Glenn Allen Redelman
Andrew Alan Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Inc
Original Assignee
Mylan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Inc filed Critical Mylan Inc
Publication of EP2863890A1 publication Critical patent/EP2863890A1/en
Publication of EP2863890A4 publication Critical patent/EP2863890A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP12880074.5A 2012-06-25 2012-06-25 Fenofibrate formulation Pending EP2863890A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/043971 WO2014003706A1 (en) 2012-06-25 2012-06-25 Fenofibrate formulation

Publications (2)

Publication Number Publication Date
EP2863890A1 EP2863890A1 (en) 2015-04-29
EP2863890A4 true EP2863890A4 (en) 2015-12-09

Family

ID=49783663

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12880074.5A Pending EP2863890A4 (en) 2012-06-25 2012-06-25 Fenofibrate formulation

Country Status (5)

Country Link
EP (1) EP2863890A4 (en)
BR (1) BR112014032579A2 (en)
CA (1) CA2877901A1 (en)
IN (1) IN2014DN11044A (en)
WO (1) WO2014003706A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101925590B1 (en) * 2016-08-30 2018-12-05 대원제약 주식회사 Formulation of fenofibric acid with improved bioavailability

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137055A1 (en) * 1999-07-09 2004-07-15 Bruno Criere Pharmaceutical composition containing fenofibrate and method for the preparation thereof
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20100166857A1 (en) * 2008-12-30 2010-07-01 Dong Yan Pharmaceutical dosage forms and methods of manufacturing same
US20110217369A1 (en) * 2009-09-03 2011-09-08 Ranbaxy Laboratories Limited Fenofibrate compositions
US20110311619A1 (en) * 2008-12-24 2011-12-22 Ethypharm Pharmaceutical formulation of nanonised fenofibrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (en) 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
RU2007133601A (en) * 2005-02-10 2009-03-20 Лайфсайкл Фарма А/С (Dk) SUSTAINABLE PHARMACEUTICAL COMPOSITION CONTAINING A FIXED DOSE OF A COMBINATION OF Phenofibrate and an HMG-CoA reductase inhibitor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137055A1 (en) * 1999-07-09 2004-07-15 Bruno Criere Pharmaceutical composition containing fenofibrate and method for the preparation thereof
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20110311619A1 (en) * 2008-12-24 2011-12-22 Ethypharm Pharmaceutical formulation of nanonised fenofibrate
US20100166857A1 (en) * 2008-12-30 2010-07-01 Dong Yan Pharmaceutical dosage forms and methods of manufacturing same
US20110217369A1 (en) * 2009-09-03 2011-09-08 Ranbaxy Laboratories Limited Fenofibrate compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2014003706A1 *

Also Published As

Publication number Publication date
EP2863890A1 (en) 2015-04-29
WO2014003706A1 (en) 2014-01-03
CA2877901A1 (en) 2014-01-03
BR112014032579A2 (en) 2017-06-27
IN2014DN11044A (en) 2015-09-25

Similar Documents

Publication Publication Date Title
HK1208372A1 (en) Liquid formulation
PL3181128T3 (en) Nilotinib pharmaceuticalcomposition
GB201111438D0 (en) Formulation
HK1204973A1 (en) Diclofenac formulations
ZA201309221B (en) Formulation
GB201216800D0 (en) Novel use
HK1202445A1 (en) New formulation
EP2827074A4 (en) Humidifier
HK1205146A1 (en) Pharmaceutical formulation
ZA201306000B (en) Stable formulation
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
EP2883547A4 (en) Medicine
ZA201402456B (en) Formulation
PL2908835T3 (en) Stable formulations
EP2827073A4 (en) Humidifier
GB201218012D0 (en) Dosage forms
EP2822599A4 (en) Vaccine formulation
GB201215502D0 (en) Medical use
SG11201406097SA (en) Capsule formulation
EP2863894A4 (en) Fenofibrate formulation
EP2863890A4 (en) Fenofibrate formulation
GB201106958D0 (en) Formulation
GB201211247D0 (en) Improved formulation
GB201206178D0 (en) Formulations
GB201206393D0 (en) Use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20151111

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/50 20060101ALI20151105BHEP

Ipc: A61K 9/48 20060101ALI20151105BHEP

Ipc: A61K 9/16 20060101ALI20151105BHEP

Ipc: A61K 9/14 20060101AFI20151105BHEP

Ipc: A61P 3/06 20060101ALI20151105BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

R17P Request for examination filed (corrected)

Effective date: 20150126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180131

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0009140000

Ipc: A61K0009160000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/06 20060101ALI20240403BHEP

Ipc: A61K 9/50 20060101ALI20240403BHEP

Ipc: A61K 9/48 20060101ALI20240403BHEP

Ipc: A61K 9/16 20060101AFI20240403BHEP

INTG Intention to grant announced

Effective date: 20240425